WASHINGTON — A controversial Food and Drug Administration working group has begun discussing how to import drugs from other countries as a way of bringing down prices for American patients, a top Trump administration health official said Monday.
“That work group has met and is outlining its plan of action,” Dan Best, senior adviser on drug pricing, said on a phone call with reporters. “As more of that information becomes available, we’ll make it available to the market.”
